Delivery Order SPE2DB20D1100-SPE2DB25FC9U8
- Not listed
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solutions, with an ultimate completion date of October 29, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,189.38 to supply Cefazolin 2 G/50 ML with Dextrose, an antibiotic medication commonly used in military and federal healthcare settings. This firm fixed-price delivery order, issued on November 25, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with dextrose solution, a commonly used antibiotic pharmaceutical product. The contract was competitively awarded on June 5, 2025, with an ultimate completion date of June 6, 2025, and reflects a firm fixed-price arrangement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.38 to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and a completion date of December 31, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a $1,585.84 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Cefazolin 2G/50ML with Dextroses, a cephalosporin antibiotic formulation commonly used in military and federal healthcare settings. This firm fixed-price, non-set-aside contract is scheduled for completion by January 14, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award represents a small-value task...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The Defense Logistics Agency awarded a $1,638 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose solution, with an ultimate completion date of October 22, 2025. The award, issued on October 21, 2025, was made without a set-aside designation through open competition. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $1,189.38 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML-Dextroses, an antibiotic medication used in clinical settings. This firm fixed price delivery order, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a $1,638.08 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous form. The contract employs firm fixed price terms with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9U8Delivery Order
The Defense Logistics Agency awarded a $3,163.02 delivery order (Contract No. 4568590593) to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML-Dextroses, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and is scheduled for completion by June 20, 2025. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's $1 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of contract awards with DLA and the Defense Health Agency, supplying specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support global military healthcare operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 6/18/25 |